Abstract:Dixing Liu, Jiana Zhong, Weiheng Wen, Yuting Ruan, Zhen Zhang, Jia Sun, Hong Chen Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China Correspondence: Hong Chen; Jia Sun Department of Endocrinology, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou, Guangdong, 510282, People's Republic of China Tel +86 13602759769 ; +86 13751822925 Email ; Purpose: Either visceral fat or muscle mass is identified to be correlated with cardiometabolic diseases, especially in type 2 diabetes (T2DM). But, the synergistical effect of visceral fat along with skeletal muscle on the risk of cardiovascular diseases (CVD) in T2DM still remains controversial. Thus, we investigated the relationship between skeletal muscle mass to visceral fat area ratio (SVR) and 10-yr CVD risk scores. Patients and Methods: A total of 291 T2DM patients aged 40– 80 years were enrolled in the current study. SVR was evaluated based on bioelectrical impedance measurements. Both Framingham risk score system and China-PAR risk model were applied to estimate future 10-yr CVD risk in T2DM population. Results: The 10-yr CVD risk scores increased with the decreased SVR tertiles in T2DM (All P< 0.001). SVR value was obviously lower in the high-risk group than that of low- or moderate-risk group (All P< 0.05). However, no significant differences were observed in BMI among different CVD risk groups. Besides, SVR was correlated with Framingham risk score (r=− 0.408; P< 0.001) and China-PAR risk score (r=− 0.336; P< 0.001). HOMA-IR, triglycerides and blood pressure were also inversely related to SVR (All P< 0.05). Furthermore, SVR value was independently correlated with both Framingham 10-yr CVD risk score (β=− 0.074, P=0.047) and China-PAR risk score (β=− 0.100, P=0.004) after adjustment for confounding factors, including age, gender, BMI, FPG, HbA1c, diabetes duration, albumin, creatinine, uric acid, smoking, blood pressure and blood lipid. The linear regression analysis was also conducted for men and women, respectively, indicating that the negative relationship between SVR and 10-yr CVD risk was observed in men but not in women. Conclusion: T2DM populations who have lower SVR value are more likely to increase CVD risk. SVR levels show marked and inverse correlation with estimated 10-yr CVD risk in T2DM, indicating that SVR could be a valuable parameter to assess the risk of CVD events in clinical practice, especially in men. Keywords: type 2 diabetes mellitus, cardiovascular diseases, skeletal muscle mass to visceral fat area ratio, risk assessment Cardiovascular diseases (CVD) remain amongst the top causes of mortality globally. While type 2 diabetes (T2DM) is known to be a major risk factor for CVD events and CVD associated mortality. 1,2 Compared with general population, patients with T2DM are 2 to 4 times more likely to develop CVD 3 and more than 50% of T2DM patients died due to cardiovascular events. 4 Currently, changes in body composition were considered as important factors for developing of CVD. 5 Among them, excessive accumulation of visceral fat was strongly correlated with cardiometabolic risk factors, including hypertension and dyslipidemia, especially in T2DM populations. 6–8 In addition to increasing visceral fat, the reduction of skeletal muscle mass was also link with CVD. A prospective research illustrated that skeletal muscle mass was inversely related to 10-yr CVD incidence after adjusting for various confounders. 9 A number of previous cross-sectional studies have also indicated that low appendicular skeletal muscle mass was significantly associated with stroke and ischemic heart disease. 10,11 Unfortunately, fat accumulation might always be combined with decreased muscle quantity, which was termed as sarcopenic obesity. Cross-sectional studies demonstrated that combined phenotypes of obesity with lower muscle mass to be positively associated with dyslipidemia, 12 metabolic syndrome, 13 and hypertension. 14 Existing work even indicated a close relationship between sarcopenic obesity and elevated Framingham CVD risk scores in Korean non-diabetic population. 15 However, several prospective studies did not consider such combined phenotype to have a higher risk for the development of CVD incidents in the elderly. 16–18 Thus, the association between visceral obesity along with low muscle mass and the hazard of CVD has not been fully clarified in T2DM. Remarkably, there is no unified diagnostic standard for sarcopenic obesity currently, which may result in the large differences in the study conclusions. 19 -Abstract Truncated-

The correlation of triglyceride/high-density lipoprotein cholesterol ratio with muscle mass in type 2 diabetes patients

Association of triglyceride–glucose index and the presence of low muscle mass in type 2 diabetes patients

Association between ALT/AST and Muscle Mass in Patients with Type 2 Diabetes Mellitus

Triglyceride-Glucose Index Levels Positively Associated with Higher Risk of Low Muscle Mass in Patients with Type 2 Diabetes

Association between serum triglyceride to high-density lipoprotein cholesterol ratio and sarcopenia among elderly patients with diabetes: a secondary data analysis of the China Health and Retirement Longitudinal Study

Association of Triglyceride–Glucose Index and the Presence of Sarcopenia in Type 2 Diabetes Patients

The Correlation Between Serum Creatine Kinase with Low Muscle Mass in Type 2 Diabetes Patients

Sex-specific Associations Between Skeletal Muscle Mass and Incident Diabetes: A Population-Based Cohort Study.

Relationship Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Cardiovascular Risk in Type 2 Diabetes

Correction: Value of Conventional Ultrasound and Shear Wave Elastography in the Assessment of Muscle Mass and Function in Elderly People with Type 2 Diabetes

Associated factors of low muscle mass in community-dwelling patients with type 2 diabetes

Association between the triglyceride glucose index and low skeletal muscle mass: a cross-sectional study

Sex-Specific Associations Between Low Muscle Mass and Glucose Fluctuations in Patients With Type 2 Diabetes Mellitus

ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients

Changes and Risk Factors of Skeletal Muscle Mass and Strength in Patients with Type 2 Diabetes over 60 Years Old: A Cross-Sectional Study from China

Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes

Analysis of Risk Factors for the Association of Sarcopenia in Patients with Type 2 Diabetes Mellitus

Prevalence and Determinant Factors of Sarcopenia in Middle Aged and Elderly Patients with Type 2 Diabetes in Beijing

Prevalence and Influencing Factors of Muscle Mass Loss in Adults with Diabetes and a High Body Fat Percentage: A Cross-Sectional Study.

613-P: Low Muscle Mass and/or Function Is Common in Type 2 Diabetes

A Study of the Relationship Between the Triglyceride-Glucose Index and Skeletal Muscle Mass in a General Chinese Population